Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "Kyung Han Nam"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Expression of c-MET in Invasive Meningioma
Sumi Yun, Jae Moon Koh, Kyu Sang Lee, An Na Seo, Kyung Han Nam, Gheeyoung Choe
J Pathol Transl Med. 2015;49(1):44-51.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.13
  • 9,425 View
  • 72 Download
  • 23 Web of Science
  • 20 Crossref
AbstractAbstract PDF
Background
Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have been reported to be involved in cancer invasion. Methods: We examined the immunohistochemical expression of c-MET and HGF in 100 cases of patients with meningiomas who have undergone complete tumor removal. Results: c-MET-High and HGFHigh were found in 17% and 13% of meningiomas, respectively. Brain invasion was observed in 17.6% of c-MET-High meningiomas, but in only 2.4% of c-MET-Low meningiomas (p=.033). Bone/ soft tissue invasion was observed in 23.5% of c-MET-High meningiomas and in 9.6% of c-MET-Low meningiomas (p=.119). HGF-High did not show statistical association with brain invasion or bone/ soft tissue invasion. c-MET-High demonstrated shorter recurrence-free survival (RFS, 93.5±8.2 months vs 96.1±1.9 months); however, this difference was not statistically significant (p=.139). There was no association of HGF-High with RFS. Conclusions: This study demonstrates that c- MET-High is associated with brain invasion of meningiomas, and that c-MET expression may be a useful predictive marker for meningioma recurrence. Patients with invasive meningiomas with high expressions of c-MET may be good candidates for targeted therapy using c-MET inhibitors.

Citations

Citations to this article as recorded by  
  • Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
    Swati Sharma, Rashmi Rana, Prem Prakash, Nirmal Kumar Ganguly
    Molecular and Cellular Biochemistry.2024; 479(1): 127.     CrossRef
  • The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
    Jun Jiang, Juan Yu, Xiajing Liu, Kan Deng, Kaichao Zhuang, Fan Lin, Liangping Luo
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review
    Ataollah Shahbandi, Darsh S. Shah, Caroline C. Hadley, Akash J. Patel
    Cancers.2023; 15(2): 483.     CrossRef
  • Advances in the systemic therapy for recurrent meningiomas and the challenges ahead
    Yi Li, Jan Drappatz
    Expert Review of Neurotherapeutics.2023; 23(11): 995.     CrossRef
  • Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases
    Thiébaud Picart, Chloé Dumot, Jacques Guyotat, Vladislav Pavlov, Nathalie Streichenberger, Alexandre Vasiljevic, Tanguy Fenouil, Anne Durand, Emmanuel Jouanneau, François Ducray, Timothée Jacquesson, Moncef Berhouma, David Meyronet
    Neurosurgical Review.2022; 45(4): 2797.     CrossRef
  • Nomogram based on MRI can preoperatively predict brain invasion in meningioma
    Jing Zhang, Yuntai Cao, Guojin Zhang, Zhiyong Zhao, Jianqing Sun, Wenyi Li, Jialiang Ren, Tao Han, Junlin Zhou, Kuntao Chen
    Neurosurgical Review.2022; 45(6): 3729.     CrossRef
  • Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma
    Farhad Mashayekhi, Soheila Talesh Sasani, Alia Saberi, Zivar Salehi
    Journal of Clinical Neuroscience.2021; 93: 1.     CrossRef
  • Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options
    Chaoying Qin, Meng Huang, Yimin Pan, Yuzhe Li, Wenyong Long, Qing Liu
    Brain Tumor Pathology.2021; 38(3): 156.     CrossRef
  • YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas
    Kathleen M. Schieffer, Vibhuti Agarwal, Stephanie LaHaye, Katherine E. Miller, Daniel C. Koboldt, Tara Lichtenberg, Kristen Leraas, Patrick Brennan, Benjamin J. Kelly, Erin Crist, Jerome Rusin, Jonathan L. Finlay, Diana S. Osorio, Eric A. Sribnick, Jeffre
    American Journal of Surgical Pathology.2021; 45(3): 329.     CrossRef
  • Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
    Rupesh Kotecha, Raees Tonse, Haley Appel, Yazmin Odia, Ritesh R. Kotecha, Guilherme Rabinowits, Minesh P. Mehta
    Current Oncology.2021; 28(2): 1537.     CrossRef
  • Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis
    Satoshi Nakasu, Yoko Nakasu
    Brain Tumor Pathology.2021; 38(2): 81.     CrossRef
  • Curcumin Inhibits HGF-Induced EMT by Regulating c-MET-Dependent PI3K/Akt/mTOR Signaling Pathways in Meningioma
    Xiaodong Chen, Fen Tian, Peng Lun, Yugong Feng, Ho Lin
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • Letter to the Editor. Preoperative seizures as predictive sign of brain invasion by meningioma
    Mikhail F. Chernov
    Journal of Neurosurgery.2019; 130(3): 1030.     CrossRef
  • Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection
    Yoon Ah Cho, Ji Myung Chung, Hyunmi Ryu, Eun Kyung Kim, Byoung Chul Cho, Sun Och Yoon
    Cancer Research and Treatment.2019; 51(3): 1052.     CrossRef
  • Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging
    Alborz Adeli, Katharina Hess, Christian Mawrin, Eileen Maria Susanne Streckert, Walter Stummer, Werner Paulus, André Kemmling, Markus Holling, Walter Heindel, Rene Schmidt, Dorothee Cäcilia Spille, Peter B. Sporns, Benjamin Brokinkel
    Oncotarget.2018; 9(89): 35974.     CrossRef
  • Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature
    A. Paix, W. Waissi, D. Antoni, R. Adeduntan, G. Noël
    Cancer/Radiothérapie.2017; 21(1): 55.     CrossRef
  • Letter: Brain Invasion in Meningiomas—Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression
    Katharina Heß, Dorothee Cäcilia Spille, Andrea Wagner, Walter Stummer, Werner Paulus, Benjamin Brokinkel
    Neurosurgery.2017; 81(2): E25.     CrossRef
  • Brain invasion in meningiomas—clinical considerations and impact of neuropathological evaluation: a systematic review
    Benjamin Brokinkel, Katharina Hess, Christian Mawrin
    Neuro-Oncology.2017; 19(10): 1298.     CrossRef
  • Systemic therapy for recurrent meningioma
    E. Le Rhun, S. Taillibert, M. C. Chamberlain
    Expert Review of Neurotherapeutics.2016; 16(8): 889.     CrossRef
  • Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis
    Dorothee Cäcilia Spille, Katharina Heß, Cristina Sauerland, Nader Sanai, Walter Stummer, Werner Paulus, Benjamin Brokinkel
    World Neurosurgery.2016; 93: 346.     CrossRef
Effects of Fixation and Storage of Human Tissue Samples on Nucleic Acid Preservation
Soo Kyung Nam, Joon Im, Yoonjin Kwak, Nayoung Han, Kyung Han Nam, An Na Seo, Hye Seung Lee
Korean J Pathol. 2014;48(1):36-42.   Published online February 25, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.1.36
  • 10,225 View
  • 167 Download
  • 37 Crossref
AbstractAbstract PDF
Background

Because of recent advances in the molecular diagnosis of cancer patients, tissue quality has become more important in daily practice.

Methods

To evaluate the effects of fixative, duration of fixation, decalcification, and storage periods on nucleic acid integrity, DNA and RNA were extracted from gastrointestinal cancer tissue. The yield and purity were analyzed, and polymerase chain reaction (PCR) for glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 60 bp), β-actin (148 bp), and human growth hormone (hGH; 434 bp) and real-time reverse transcription-PCR for β-actin (97 bp) were performed.

Results

All formalin-fixed paraffin-embedded (FFPE) and methacarn-fixed paraffin-embedded (MFPE) samples tested positive for GAPDH and β-actin by PCR. hGH was successfully detected in all MFPE samples, but in only 46.7% of the FFPE samples. Prolonged formalin fixation resulted in fewer GAPDH and β-actin PCR products, and amplification of hGH was not successful. The PCR and reverse transcription-PCR results were significantly affected by the duration of decalcification. The yield, purity, and integrity of mRNA progressively decreased with increased storage periods of paraffin blocks.

Conclusions

Fixation and storage should therefore be standardized in order to improve the quality of molecular pathologic diagnosis.

Citations

Citations to this article as recorded by  
  • InDEL instability in two different tumoral tissues and its forensic significance
    İpek Gürel, Faruk Aşıcıoğlu, Gökhan Ersoy, Özlem Bülbül, Tülin Öztürk, Gönül Filoğlu
    Forensic Science, Medicine and Pathology.2024;[Epub]     CrossRef
  • Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing
    Chihiro Mimura, Rei Takamiya, Shodai Fujimoto, Takafumi Fukui, Atsuhiko Yatani, Jun Yamada, Mizuki Takayasu, Naoya Takata, Hiroki Sato, Kiyoko Fukuda, Koichi Furukawa, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Shingo Matsumoto, Koichi Goto, Mot
    BMC Cancer.2024;[Epub]     CrossRef
  • Predictive molecular pathology after prolonged fixation: A study on tissue from anatomical body donors
    Anja Böckers, Leon Schurr, Michael Schön, Tatjana Scholl, Tobias M. Böckers, Konrad Steinestel, Annette Arndt
    Experimental and Molecular Pathology.2024; 137: 104899.     CrossRef
  • Tiempos y condiciones de almacenamiento de las muestras en anatomía patológica. Recomendaciones de la Sociedad Española de Anatomía Patológica parte 1: muestras destinadas al diagnóstico
    Francesc Tresserra Casas, Esther Rosello Sastre, María Jesús Fernández Aceñero, Lara Zaragoza Macián, Javier Azúa Romeo, Clara Alfaro-Cervelló, Samuel Navarro Fos, Eugenia García Fernández, Jordi Temprana-Salvador, Mar Iglesias Coma, Francesc Olivares Veg
    Revista Española de Patología.2024; 57(4): 235.     CrossRef
  • RNA-Seq Analysis in Non-Small Cell Lung Cancer: What Is the Best Sample from Clinical Practice?
    Lorenzo Nibid, Giovanna Sabarese, Luca Andreotti, Benedetta Canalis, Daniela Righi, Filippo Longo, Margherita Grazi, Pierfilippo Crucitti, Giuseppe Perrone
    Journal of Personalized Medicine.2024; 14(8): 851.     CrossRef
  • A Study on the Stainability and DNA Conservation of Tissue Slides according to Fixation Time and Temperature
    Da-som JEONG
    Korean Journal of Clinical Laboratory Science.2024; 56(3): 217.     CrossRef
  • Selection and Evaluation of mRNA and miRNA Reference Genes for Expression Studies (qPCR) in Archived Formalin-Fixed and Paraffin-Embedded (FFPE) Colon Samples of DSS-Induced Colitis Mouse Model
    Ana Unkovič, Emanuela Boštjančič, Aleš Belič, Martina Perše
    Biology.2023; 12(2): 190.     CrossRef
  • The quality of DNA isolated from autopsy formalin-fixed and formalin-fixed paraffin-embedded tissues: study of 1662 samples
    Katarina Vitošević, Danijela Todorović, Živana Slović, Tatjana Varljen, Ivana Radaković, Dušan Radojević, Vanja Čanović, Miloš Todorović
    Molecular Biology Reports.2023; 50(8): 6323.     CrossRef
  • Morphometric and Molecular Analysis of Five-Spine Epidinium Morphotypes Taken from the Rumen of European Bison, Bison bonasus
    Silvia Ivorová, Anna Kopčaková, Peter Pristaš, Svetlana Kišidayová
    Life.2023; 13(12): 2350.     CrossRef
  • Retrieving high-quality genomic DNA from formalin-fixed paraffin-embedded tissues for multiple molecular analyses
    Ha Thi Nguyen, Vinay Bharadwaj Tatipamula, Duy Ngoc Do, Thien Chi Huynh, Mai Kim Dang
    Preparative Biochemistry & Biotechnology.2022; 52(1): 48.     CrossRef
  • Evaluation of DNA Isolation and Amplification from Various Organs Preserved through Frozen, Formalin-Fixed and Paraffin-Embedded Tissue Sample method
    Mifta Rizqina Amalia, Anna Roosdiana, Yudit Oktanella, Andreas Bandang Hardian, Dini Agusti Paramanandi, Kharisma Kurnia Utami, Andi Tri Rakhmat Akbar, Made Venika Nareswari, Fajar Shodiq Permata
    Journal of Experimental Biology and Agricultural Sciences.2022; 10(3): 643.     CrossRef
  • DNA isolated from formalin-fixed paraffin-embedded healthy tissue after 30 years of storage can be used for forensic studies
    Katarina Vitošević, Miloš Todorović, Živana Slović, Tatjana Varljen, Stevan Matić, Danijela Todorović
    Forensic Science, Medicine and Pathology.2021; 17(1): 47.     CrossRef
  • Extraction of DNA and RNA from Formalin-fixed Paraffin-embedded Tissue Specimens
    NIdhi Shukla, Narmadhaa Siva, Madhu Sivakumar, Rabia Parveen, Ashwani Mishra, Avadh Shah, Krishna Medicherla, Prashanth Suravajhala
    BIO-PROTOCOL.2021;[Epub]     CrossRef
  • Cyclin dependent kinase inhibitor 2A and miR-671-5p expression profile in Iranian glioblastoma multiforme
    Tayyebali Salmani, Sayyed Mohammad Hossein Ghaderian, Mohammadreza Hajiesmaeili, Omidvar Rezaei Mirghaed, Azadeh Rakhshan, Mohammad Javad Nasiri, Mahan Mohammadi
    Gene Reports.2020; 19: 100620.     CrossRef
  • Comparison between Fluorescence in-situ Hybridization (FISH), Reverse Transcriptase PCR (RT-PCR) and fragment analysis, for detection of t (X; 18) (p11; q11) translocation in synovial sarcomas
    Omshree Shetty, Trupti Pai, Mamta Gurav, Bharat Rekhi
    Indian Journal of Pathology and Microbiology.2020; 63(1): 64.     CrossRef
  • Comparison of HPV detection rate in formalin‐fixed paraffin‐embedded tissues of head and neck carcinoma using two DNA extraction kits and three amplification methods
    Ljiljana Božić, Tanja Jovanović, Aleksandra Šmitran, Marko Janković, Aleksandra Knežević
    European Journal of Oral Sciences.2020; 128(6): 501.     CrossRef
  • Formalin Fixation of Human Healthy Autopsied Tissues: The Influence of Type of Tissue, Temperature and Incubation Time on the Quality of Isolated DNA
    Danijela Todorovic, Katarina Vitosevic, Milos Todorovic, Zivana Slovic
    Serbian Journal of Experimental and Clinical Research .2020; 21(4): 307.     CrossRef
  • Detection of Disease-specific Fusion Genes of Soft Tissue Tumors Using Formalin-fixed Paraffin-embedded Tissues; Its Diagnostic Usefulness and Factors Affecting the Detection Rates
    Takahiro Matsushige, Satoshi Kuwamoto, Michiko Matsushita, Lusi Oka Wardhani, Yasushi Horie, Kazuhiko Hayashi, Yukisato Kitamura
    Yonago Acta Medica.2019; 62(1): 115.     CrossRef
  • The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality
    Latarsha J. Carithers, Rachana Agarwal, Ping Guan, Hana Odeh, Michael C. Sachs, Kelly B. Engel, Sarah R. Greytak, Mary Barcus, Conrado Soria, Chih-Jian (Jason) Lih, P. Mickey Williams, Philip A. Branton, Leslie Sobin, Benjamin Fombonne, Therese Bocklage,
    Archives of Pathology & Laboratory Medicine.2019; 143(9): 1106.     CrossRef
  • Pathobiology and innate immune responses of gallinaceous poultry to clade 2.3.4.4A H5Nx highly pathogenic avian influenza virus infection
    Kateri Bertran, Mary J. Pantin-Jackwood, Miria F. Criado, Dong-Hun Lee, Charles L. Balzli, Erica Spackman, David L. Suarez, David E. Swayne
    Veterinary Research.2019;[Epub]     CrossRef
  • Optimized Storage Methods of RNA Extraction from Formalin Fixed Paraffin Embedded Tissue
    Mehdi Barati, Mahdieh Shokrollahi Barough, Fatemeh Pak, Vahid Semnani, Mehrnoosh Pashaei, Parviz Kokhaei
    Middle East Journal of Rehabilitation and Health.2018;[Epub]     CrossRef
  • Effect of formalin fixation on pcr amplification of DNA isolated from healthy autopsy tissues
    Katarina Vitošević, Miloš Todorović, Tatjana Varljen, Živana Slović, Stevan Matić, Danijela Todorović
    Acta Histochemica.2018; 120(8): 780.     CrossRef
  • Evaluation of the optimal provision of formalin-fixed, paraffin-embedded material for reverse transcription-PCR in soft-tissue tumour diagnosis
    Khin Thway, Dorte Wren, Jasmin Lee, Lisa Thompson, Cyril Fisher, David Gonzalez
    Journal of Clinical Pathology.2017; 70(1): 20.     CrossRef
  • Molecular Testing for Gastrointestinal Cancer
    Hye Seung Lee, Woo Ho Kim, Yoonjin Kwak, Jiwon Koh, Jeong Mo Bae, Kyoung-Mee Kim, Mee Soo Chang, Hye Seung Han, Joon Mee Kim, Hwal Woong Kim, Hee Kyung Chang, Young Hee Choi, Ji Y. Park, Mi Jin Gu, Min Jin Lhee, Jung Yeon Kim, Hee Sung Kim, Mee-Yon Cho
    Journal of Pathology and Translational Medicine.2017; 51(2): 103.     CrossRef
  • Reference genes for studies in infectious parasitic diseases in five types of human tissues
    Cristina Silva Meira-Strejevitch, Vera Lucia Pereira-Chioccola, Marta Marques Maia, Daise Damaris Carnietto de Hippolito, Hui-Tzu Lin Wang, Gabriela Motoie, Aparecida Helena de Souza Gomes, Cristina Takami Kanamura, Roosecelis Brasil Martines, Cinara Cáss
    Gene Reports.2017; 7: 98.     CrossRef
  • Establishment of a primary culture of polymorphous low grade adenocarcinoma cells
    Lucas Novaes Teixeira, Victor Angelo Martins Montalli, Silvia Borges Pimentel de Oliveira, Thais Fernanda Santos Toledo, Elizabeth Ferreira Martinez, Vera Cavalcanti de Araújo
    Archives of Oral Biology.2017; 82: 188.     CrossRef
  • DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks
    Alice Guyard, Alice Boyez, Anaïs Pujals, Cyrielle Robe, Jeanne Tran Van Nhieu, Yves Allory, Julien Moroch, Odette Georges, Jean-Christophe Fournet, Elie-Serge Zafrani, Karen Leroy
    Virchows Archiv.2017; 471(4): 491.     CrossRef
  • Prevalence of exon 11 internal tandem duplications in the C‐KIT proto‐oncogene in Australian canine mast cell tumours
    VS Tamlin, AE Kessell, RJ Mccoy, EC Dobson, TS Smith, M Hebart, L Brown, D Mitrovic, AE Peaston
    Australian Veterinary Journal.2017; 95(10): 386.     CrossRef
  • Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples
    Rou Chen, Qingzhou Guan, Jun Cheng, Jun He, Huaping Liu, Hao Cai, Guini Hong, Jiahui Zhang, Na Li, Lu Ao, Zheng Guo
    Oncotarget.2017; 8(4): 6652.     CrossRef
  • Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system
    Sayaka Yuzawa, Hiroshi Nishihara, Shigeru Yamaguchi, Hiromi Mohri, Lei Wang, Taichi Kimura, Masumi Tsuda, Mishie Tanino, Hiroyuki Kobayashi, Shunsuke Terasaka, Kiyohiro Houkin, Norihiro Sato, Shinya Tanaka
    Modern Pathology.2016; 29(7): 708.     CrossRef
  • Comparison of the Diagnostic Value Between Real-Time Reverse Transcription-Polymerase Chain Reaction Assay and Histopathologic Examination in Sentinel Lymph Nodes for Patients With Gastric Carcinoma
    Yoonjin Kwak, Soo Kyung Nam, Eun Shin, Sang-Hoon Ahn, Hee Eun Lee, Do Joong Park, Woo Ho Kim, Hyung-Ho Kim, Hye Seung Lee
    American Journal of Clinical Pathology.2016; 145(5): 651.     CrossRef
  • WITHDRAWN: Selection of reference genes in five types of human tissues for normalization of gene expression studies in infectious diseases
    Cristina Silva Meira-Strejevitch, Vera Lucia Pereira-Chioccola, Marta Marques Maia, Daise Damaris Carnietto de Hipólito, Hui-Tzu Lin Wang, Gabriela Motoie, Aparecida Helena de Souza Gomes, Cristina Takami Kanamura, Roosecelis Brasil Martines, Cinara Cássi
    Gene.2016;[Epub]     CrossRef
  • A Comparison of Fresh Frozen vs. Formalin-Fixed, Paraffin-Embedded Specimens of Canine Mammary Tumors via Branched-DNA Assay
    Florenza Lüder Ripoli, Annika Mohr, Susanne Conradine Hammer, Saskia Willenbrock, Marion Hewicker-Trautwein, Silvia Hennecke, Hugo Murua Escobar, Ingo Nolte
    International Journal of Molecular Sciences.2016; 17(5): 724.     CrossRef
  • Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancer
    Sousana Amptoulach, Andreas C. Lazaris, Ioanna Giannopoulou, Nikolaos Kavantzas, Efstratios Patsouris, Nikolaos Tsavaris
    Medical Oncology.2015;[Epub]     CrossRef
  • The Importance of Reference Gene Analysis of Formalin-Fixed, Paraffin-Embedded Samples from Sarcoma Patients — An Often Underestimated Problem
    Ninna Aggerholm-Pedersen, Akmal Safwat, Steen Bærentzen, Marianne Nordsmark, Ole Steen Nielsen, Jan Alsner, Brita S. Sørensen
    Translational Oncology.2014; 7(6): 687.     CrossRef
  • Comparison of histomorphology and DNA preservation produced by fixatives in the veterinary diagnostic laboratory setting
    William F. Craft, Julia A. Conway, Michael J. Dark
    PeerJ.2014; 2: e377.     CrossRef
  • Histotechnical solutions for quality improvement of nucleic acid specimens extracted from paraffin blocks
    A. N Vaganova
    Genes & Cells.2014; 9(2): 96.     CrossRef
Immunohistochemical Classification of Primary and Secondary Glioblastomas
Kyu Sang Lee, Gheeyoung Choe, Kyung Han Nam, An Na Seo, Sumi Yun, Kyung Ju Kim, Hwa Jin Cho, Sung Hye Park
Korean J Pathol. 2013;47(6):541-548.   Published online December 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.6.541
  • 7,434 View
  • 63 Download
  • 16 Crossref
AbstractAbstract PDF
Background

Glioblastomas may develop de novo (primary glioblastomas, P-GBLs) or through progression from lower-grade astrocytomas (secondary glioblastomas, S-GBLs). The aim of this study was to compare the immunohistochemical classification of glioblastomas with clinically determined P-GBLs and S-GBLs to identify the best combination of antibodies for immunohistochemical classification.

Methods

We evaluated the immunohistochemical expression of epidermal growth factor receptor (EGFR), p53, and isocitrate dehydrogenase 1 (IDH-1) in 150 glioblastoma cases.

Results

According to clinical history, the glioblastomas analyzed in this study consisted of 146 P-GBLs and 4 S-GBLs. Immunohistochemical expression of EGFR, p53, and IDH-1 was observed in 62.6%, 49.3%, and 11.1%, respectively. Immunohistochemical profiles of EGFR(+)/p53(-), IDH-1(-)/EGFR(+)/p53(-), and EGFR(-)/p53(+) were noted in 41.3%, 40.2%, and 28.7%, respectively. Expression of IDH-1 and EGFR(-)/p53(+) was positively correlated with young age. The typical immunohistochemical features of S-GBLs comprised IDH-1(+)/EGFR(-)/p53(+), and were noted in 3.6% of clinically P-GBLs. The combination of IDH-1(-) or EGFR(+) was the best set of immunohistochemical stains for identifying P-GBLs, whereas the combination of IDH-1(+) and EGFR(-) was best for identifying S-GBLs.

Conclusions

We recommend a combination of IDH-1 and EGFR for immunohistochemical classification of glioblastomas. We expect our results to be useful for determining treatment strategies for glioblastoma patients.

Citations

Citations to this article as recorded by  
  • Cutaneous Melanoma and Glioblastoma Multiforme Association—Case Presentation and Literature Review
    Olguța Anca Orzan, Călin Giurcăneanu, Bogdan Dima, Monica Beatrice Dima, Ana Ion, Beatrice Bălăceanu, Cornelia Nițipir, Irina Tudose, Cătălina Andreea Nicolae, Alexandra Maria Dorobanțu
    Diagnostics.2023; 13(6): 1046.     CrossRef
  • Primary Extra-axial Glioblastoma: Case Report and Literature Review
    Baraa Dabboucy, Philippe Younes, Abdallah Rahbani, Elie Fahed, Gérard Abadjian
    Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery.2021; 40(04): e368.     CrossRef
  • TERT Promoter Mutation in Adult Glioblastomas
    Mukesh Barange, Sridhar Epari, Mamta Gurav, Omshree Shetty, Ayushi Sahay, Prakash Shetty, Jayantsastri Goda, Aliasagar Moyiadi, Tejpal Gupta, Rakesh Jalali
    Neurology India.2021; 69(1): 126.     CrossRef
  • Immunohistochemical characterisation and histopathology of astrocytic neoplasms at a tertiary Nigerian hospital
    Michael Nweke, Gabriel Ogun, Amos Adeleye, Clement A. Okolo, Adekunle Adesina
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Cytotoxic Effects of Blue Scorpion Venom (Rhopalurus junceus) in a Glioblastoma Cell Line Model
    Laura A. Lozano-Trujillo, Diana K. Garzón-Perdomo, Andrea C.R. Vargas, Lina M. de los Reyes, Marco F. Avila-Rodriguez, Olivia T.G. Gay, Liliana F. Turner
    Current Pharmaceutical Biotechnology.2021; 22(5): 636.     CrossRef
  • Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers
    Ádám Nagy, Ferenc Garzuly, Gergely Padányi, Iván Szűcs, Ádám Feldmann, Balázs Murnyák, Tibor Hortobágyi, Bernadette Kálmán
    Pathology & Oncology Research.2019; 25(1): 21.     CrossRef
  • Proteomic Advances in Glial Tumors through Mass Spectrometry Approaches
    Radu Pirlog, Sergiu Susman, Cristina Adela Iuga, Stefan Ioan Florian
    Medicina.2019; 55(8): 412.     CrossRef
  • Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience
    Homan Mohammadi, Kevin Shiue, G Daniel Grass, Vivek Verma, Kay Engellandt, Dirk Daubner, Gabriele Schackert, Mercia J Gondim, Dibson Gondim, Alexander O Vortmeyer, Aaron P Kamer, William Jin, Timothy J Robinson, Gordon Watson, Hsiang-Hsuan M Yu, Tim Laute
    Neuro-Oncology Practice.2019;[Epub]     CrossRef
  • Calvarium mass as the first presentation of glioblastoma multiforme: A very rare manifestation of high-grade glioma
    S. Taghipour Zahir, M. Mortaz, M. Baghi Yazdi, N. Sefidrokh Sharahjin, M. Shabani
    Neurochirurgie.2018; 64(1): 76.     CrossRef
  • Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
    Ewa Izycka-Swieszewska, Ewa Bien, Joanna Stefanowicz, Edyta Szurowska, Ewa Szutowicz-Zielinska, Magdalena Koczkowska, Dawid Sigorski, Wojciech Kloc, Wojciech Rogowski, Elzbieta Adamkiewicz-Drozynska
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Prognostic significance of mutant IDH1, CD133, and β-catenin immunohistochemical expression in glioblastoma multiforme
    Azza Abdel-Aziz, Mie A. Mohamed, Dina Abdallah, Fatma M.F. Akl, Ghada E. Eladawy, Ahmed N. Taha, Hossam Shata
    Egyptian Journal of Pathology.2018; 38(1): 27.     CrossRef
  • On glioblastoma and the search for a cure: where do we stand?
    John Bianco, Chiara Bastiancich, Aleksander Jankovski, Anne des Rieux, Véronique Préat, Fabienne Danhier
    Cellular and Molecular Life Sciences.2017; 74(13): 2451.     CrossRef
  • Development of Glioblastoma after Treatment of Brain Abscess
    Hiroaki Matsumoto, Hiroaki Minami, Shogo Tominaga, Yasuhisa Yoshida
    World Neurosurgery.2016; 88: 686.e19.     CrossRef
  • Clinical, immunohistochemical, and molecular genetic prognostic factors in adult patients with glioblastoma
    N. V. Lobanova, L. V. Shishkina, M. V. Ryzhova, G. L. Kobyakov, R. V. Sycheva, S. A. Burov, A. V. Lukyanov, Zh. R. Omarova
    Arkhiv patologii.2016; 78(4): 10.     CrossRef
  • Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma
    Jung-Soo Pyo, Nae Yu Kim, Roy Hyun Jai Kim, Guhyun Kang
    Brain Tumor Pathology.2016; 33(4): 248.     CrossRef
  • Methyl Guanine Methyl Transferase Methylation Status and Epidermal Growth Factor Receptor expression in a cohort of Egyptian glioblastoma patients
    Soheir M. Hamam, Bassma M. El Sabaa, Iman M. Talaat, Rasha A. Nassra, Doaa A. Abdelmonsif
    Egyptian Journal of Pathology.2016; 36(2): 282.     CrossRef
ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients
Cheol Lee, Jeong Whan Park, Ja Hee Suh, Kyung Han Nam, Kyung Chul Moon
Korean J Pathol. 2013;47(5):452-457.   Published online October 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.5.452
  • 7,542 View
  • 66 Download
  • 28 Crossref
AbstractAbstract PDF
Background

Recently, there have been a few reports of renal cell carcinoma (RCC) cases with anaplastic lymphoma kinase (ALK) gene fusion. In this study, we screened consecutively resected RCCs from a single institution for ALK protein expression by immunohistochemistry, and then we performed fluorescence in situ hybridization to confirm the ALK gene alteration in ALK immunohistochemistry-positive cases.

Methods

We screened 829 RCCs by ALK immunohistochemistry, and performed fluorescence in situ hybridization analysis using ALK dual-color break-apart rearrangement probe. Histological review and additional immunohistochemistry analyses were done in positive cases.

Results

One ALK-positive case was found. Initial diagnosis of this case was papillary RCC type 2. This comprises 0.12% of all RCCs (1/829) and 1.9% of papillary RCCs (1/53). This patient was a 44-year-old male with RCC found during routine health check-up. He was alive without evidence of disease 12 years after surgery. The tumor showed a papillary and tubular pattern, and showed positivity for CD10 (focal), epithelial membrane antigen, cytokeratin 7, pan-cytokeratin, PAX-2, and vimentin.

Conclusions

We found the first RCC case with ALK gene rearrangement in Korean patients by ALK immunohistochemistry among 829 RCCs. This case showed similar histological and immunohistochemical features to those of previous adult cases with ALK rearrangement, and showed relatively good prognosis.

Citations

Citations to this article as recorded by  
  • ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum
    Ming Zhao, Xiaona Yin, Xiaoqun Yang, Hualei Gan, Ni Chen, Guangjie Duan, Yanfeng Bai, Xiaodong Teng, Jiayun Xu, Rong Fang, Suying Wang, Shan Zhong, Xiaotong Wang, Lisong Teng
    Modern Pathology.2024; 37(8): 100536.     CrossRef
  • Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
    Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga, Mario Roselli, Francesco Torino
    International Journal of Molecular Sciences.2022; 23(7): 3995.     CrossRef
  • Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
    Kiril Trpkov, Sean R. Williamson, Anthony J. Gill, Adebowale J. Adeniran, Abbas Agaimy, Reza Alaghehbandan, Mahul B. Amin, Pedram Argani, Ying-Bei Chen, Liang Cheng, Jonathan I. Epstein, John C. Cheville, Eva Comperat, Isabela Werneck da Cunha, Jennifer B
    Modern Pathology.2021; 34(6): 1167.     CrossRef
  • ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification
    Farshid Siadat, Kiril Trpkov
    Cancers.2020; 12(1): 168.     CrossRef
  • ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology
    Jen-Fan Hang, Hsiao-Jen Chung, Chin-Chen Pan
    Virchows Archiv.2020; 476(6): 921.     CrossRef
  • Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion
    Chang Gok Woo, Seok Jung Yun, Seung-Myoung Son, Young Hyun Lim, Ok-Jun Lee
    Yonsei Medical Journal.2020; 61(3): 262.     CrossRef
  • Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers
    Sean R. Williamson, Anthony J. Gill, Pedram Argani, Ying-Bei Chen, Lars Egevad, Glen Kristiansen, David J. Grignon, Ondrej Hes
    American Journal of Surgical Pathology.2020; 44(7): e47.     CrossRef
  • ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217
    Naoto Kuroda, Kiril Trpkov, Yuan Gao, Maria Tretiakova, Yajuan J. Liu, Monika Ulamec, Kengo Takeuchi, Abbas Agaimy, Christopher Przybycin, Cristina Magi-Galluzzi, Soichiro Fushimi, Fumiyoshi Kojima, Malthide Sibony, Jen-Fan Hang, Chin-Chen Pan, Asli Yilma
    Modern Pathology.2020; 33(12): 2564.     CrossRef
  • ALK rearrangement in TFE3-positive renal cell carcinoma: Alternative diagnostic option to exclude Xp11.2 translocation carcinoma
    Yiqi Zhu, Ning Liu, Wei Guo, Xiaohong Pu, Hongqian Guo, Weidong Gan, Dongmei Li
    Pathology - Research and Practice.2020; 216(12): 153286.     CrossRef
  • New and emerging renal entities: a perspective post‐WHO 2016 classification
    Kiril Trpkov, Ondřej Hes
    Histopathology.2019; 74(1): 31.     CrossRef
  • Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics
    Samer Nassif, Ziad M. El-Zaatari, Michel Attieh, Maya Hijazi, Najla Fakhreddin, Tarek Aridi, Fouad Boulos
    Medicine.2019; 98(32): e16702.     CrossRef
  • Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait
    Xiao-tong Wang, Ru Fang, Sheng-bing Ye, Ru-song Zhang, Rui Li, Xuan Wang, Rong-hao Ji, Zhen-feng Lu, Heng-hui Ma, Xiao-jun Zhou, Qiu-yuan Xia, Qiu Rao
    Pathology - Research and Practice.2019; 215(11): 152651.     CrossRef
  • ALK-rearranged renal cell carcinomas in Polish population
    Adam Gorczynski, Piotr Czapiewski, Aleksandra Korwat, Lukasz Budynko, Monika Prelowska, Krzysztof Okon, Wojciech Biernat
    Pathology - Research and Practice.2019; 215(12): 152669.     CrossRef
  • ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review
    Jing Yang, Lei Dong, Hong Du, Xiu-bo Li, Yan-xiao Liang, Guo-rong Liu
    Diagnostic Pathology.2019;[Epub]     CrossRef
  • Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach
    Reza Alaghehbandan, Delia Perez Montiel, Ana Silvia Luis, Ondrej Hes
    Cancers.2019; 12(1): 85.     CrossRef
  • ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review
    Yohan Bodokh, Damien Ambrosetti, Valérie Kubiniek, Branwel Tibi, Matthieu Durand, Jean Amiel, Morgane Pertuit, Anne Barlier, Florence Pedeutour
    Cancer Genetics.2018; 221: 31.     CrossRef
  • Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma
    Yong Jin Cho, Soo Hee Kim, Eun Kyung Kim, Jung Woo Han, Kyoo-Ho Shin, Hyuk Hu, Kyung Sik Kim, Young Deuk Choi, Sunghoon Kim, Young Han Lee, Jin-Suck Suh, Joong Bae Ahn, Hyun Cheol Chung, Sung Hoon Noh, Sun Young Rha, Sung-Taek Jung, Hyo Song Kim
    BMC Cancer.2018;[Epub]     CrossRef
  • Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma
    Sumanta K. Pal, Paulo Bergerot, Nazli Dizman, Cristiane Bergerot, Jacob Adashek, Russell Madison, Jon H. Chung, Siraj M. Ali, Jeremy O. Jones, Ravi Salgia
    European Urology.2018; 74(1): 124.     CrossRef
  • Genetic analysis and clinicopathological features of ALK‐rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review
    Wenjuan Yu, Yuewei Wang, Yanxia Jiang, Wei Zhang, Yujun Li
    Histopathology.2017; 71(1): 53.     CrossRef
  • A case of anaplastic lymphoma kinase‐positive renal cell carcinoma coincident with Hodgkin lymphoma
    Yuzo Oyama, Haruto Nishida, Takahiro Kusaba, Hiroko Kadowaki, Motoki Arakane, Tsutomu Daa, Dai Watanabe, Yasuyuki Akita, Fuminori Sato, Hiromitsu Mimata, Shigeo Yokoyama
    Pathology International.2017; 67(12): 626.     CrossRef
  • Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas
    An Na Seo, Ghilsuk Yoon, Jae Y. Ro
    Advances in Anatomic Pathology.2017; 24(2): 65.     CrossRef
  • The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications
    Soo Hee Kim, Woo Ick Yang, Yoo Hong Min, Young Hyeh Ko, Sun Och Yoon
    Tumor Biology.2016; 37(2): 2037.     CrossRef
  • New and emerging renal tumour entities
    Naoto Kuroda, Ondřej Hess, Ming Zhou
    Diagnostic Histopathology.2016; 22(2): 47.     CrossRef
  • ALK‐rearranged renal cell carcinomas in children
    Mariana M. Cajaiba, Lawrence J. Jennings, Stephen M. Rohan, Antonio R. Perez‐Atayde, Adrian Marino‐Enriquez, Jonathan A. Fletcher, James I. Geller, Katrin M. C. Leuer, Julia A. Bridge, Elizabeth J. Perlman
    Genes, Chromosomes and Cancer.2016; 55(5): 442.     CrossRef
  • Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene
    Hironori Kusano, Yuki Togashi, Jun Akiba, Fukuko Moriya, Katsuyoshi Baba, Naomi Matsuzaki, Yoshiaki Yuba, Yusuke Shiraishi, Hiroshi Kanamaru, Naoto Kuroda, Seiji Sakata, Kengo Takeuchi, Hirohisa Yano
    American Journal of Surgical Pathology.2016; 40(6): 761.     CrossRef
  • Expanding the spectrum of ALK‐rearranged renal cell carcinomas in children: Identification of a novel HOOK1‐ALK fusion transcript
    Mariana M. Cajaiba, Lawrence J. Jennings, David George, Elizabeth J. Perlman
    Genes, Chromosomes and Cancer.2016; 55(10): 814.     CrossRef
  • TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation
    Paul Scott Thorner, Mary Shago, Paula Marrano, Furqan Shaikh, Gino R. Somers
    Pathology - Research and Practice.2016; 212(10): 937.     CrossRef
  • ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult
    Marie Jeanneau, Valerie Gregoire, Claude Desplechain, Fabienne Escande, Dan Petre Tica, Sebastien Aubert, Xavier Leroy
    Pathology - Research and Practice.2016; 212(11): 1064.     CrossRef
Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
Cheol Lee, Jeong-Whan Park, Ja Hee Suh, Kyung Han Nam, Kyung Chul Moon
Korean J Pathol. 2013;47(5):426-432.   Published online October 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.5.426
  • 9,302 View
  • 77 Download
  • 17 Crossref
AbstractAbstract PDF
Background

Due to advancements in treatment of metastatic and advanced renal cell carcinoma (RCC), it has become increasingly important to diagnose metastatic RCC and the specific subtype. In this study, we investigated the diverse histologic features of metastatic clear cell renal cell carcinoma (CCRCC) cases in comparison with corresponding primary lesions.

Methods

We identified 119 metastatic CCRCC cases from 81 corresponding primary lesions diagnosed between 1995 and 2010 and evaluated the diverse histologic and immunohistochemical features of these lesions.

Results

A total of 44 primary lesions (54.3%) had a non-clear cell component in addition to a typical clear cell component. Of the 119 metastatic lesions, 63 lesions (52.9%) contained a non-clear cell component, and 29 metastatic lesions were composed of a non-clear cell component only. Rhabdoid features were the most frequent non-clear cell histology among the metastatic lesions. Metastatic CCRCCs mainly showed positive CD10 and epithelial membrane antigen staining and negative cytokeratin 7 staining.

Conclusions

Metastatic CCRCC commonly showed a variety of histologic features. If there is a difficulty to diagnose metastatic CCRCC due to a variety of histologic features or small biopsy specimen, histologic review of the primary lesion and immunohistochemical analysis can help determine the correct diagnosis.

Citations

Citations to this article as recorded by  
  • Sarcomatoid and Rhabdoid Renal Cell Carcinoma
    Adebowale J. Adeniran, Brian Shuch, Peter A. Humphrey
    American Journal of Surgical Pathology.2024; 48(7): e65.     CrossRef
  • Emerging Antibody-Drug Conjugate Therapies and Targets for Metastatic Renal Cell Carcinoma
    Harrison C. Gottlich, Reza Nabavizadeh, Mihai Dumbrava, Rodrigo Rodrigues Pessoa, Ahmed M. Mahmoud, Ishita Garg, Jacob Orme, Brian A. Costello, John Cheville, Fabrice Lucien
    Kidney Cancer.2023; 7(1): 161.     CrossRef
  • Painful, bleeding fingertip papule
    Jane Gay, Sarah Simpson, Patrick Rush, Alex Holliday
    JAAD Case Reports.2022; 21: 130.     CrossRef
  • Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
    Rory M. Bade, Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino, Joshua A. Desotelle, Erika Heninger, Charlotte N. Stahlfeld, Jamie M. Sperger, Anupama Singh, Serena K. Wolfe, David J. Niles, Waddah Arafat, John
    Molecular Oncology.2021; 15(9): 2330.     CrossRef
  • Laparoscopic cytoreductive nephrectomy and adrenalectomy for metachronous RCC metastases—Case report
    Bogdan Petrut, Cristina Eliza Bujoreanu, Vasile Vlad Hardo, Adrian Barbos, Bogdan Fetica
    International Journal of Surgery Case Reports.2020; 74: 268.     CrossRef
  • Does CARMENA mark the end of cytoreductive nephrectomy for metastatic renal cell carcinoma?
    Steven L. Chang, Toni K. Choueiri, Lauren C. Harshman
    Urologic Oncology: Seminars and Original Investigations.2019; 37(8): 525.     CrossRef
  • Metastatic TFE3-overexpressing renal clear cell carcinoma with dense granules: a histological, immunohistochemical, and ultrastructural study
    Shoujun Chen, Elba A. Turbat-Herrera, Guillermo A. Herrera, Meghna Chadha, Rodney E. Shackelford, Eric X. Wei
    Ultrastructural Pathology.2018; 42(4): 369.     CrossRef
  • The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma
    Rana R. McKay, Dominick Bossé, Wanling Xie, Stephanie A.M. Wankowicz, Abdallah Flaifel, Raphael Brandao, Aly-Khan A. Lalani, Dylan J. Martini, Xiao X. Wei, David A. Braun, Eliezer Van Allen, Daniel Castellano, Guillermo De Velasco, J. Connor Wells, Daniel
    Cancer Immunology Research.2018; 6(7): 758.     CrossRef
  • Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma
    Cheol Lee, Bohyun Kim, Boram Song, Kyung Chul Moon
    Journal of Pathology and Translational Medicine.2017; 51(4): 359.     CrossRef
  • Pulmonary metastasectomy from renal cell carcinoma including 3 cases with sarcomatoid component
    Tsuyoshi Ueno, Motohiro Yamashita, Shigeki Sawada, Ryujiro Sugimoto, Noriko Nishijima, Yoshifumi Sugawara, Iku Ninomiya
    General Thoracic and Cardiovascular Surgery.2016; 64(3): 149.     CrossRef
  • Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?
    Aleksandra Semeniuk-Wojtaś, Rafał Stec, Cezary Szczylik
    Urologic Oncology: Seminars and Original Investigations.2016; 34(5): 215.     CrossRef
  • Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma
    Sarah P. Psutka, John C. Cheville, Brian A. Costello, Suzanne B. Stewart-Merrill, Christine M. Lohse, Bradley C. Leibovich, Stephen A. Boorjian, R. Houston Thompson
    Urology.2016; 96: 106.     CrossRef
  • The Correlation of Tissue-Based Biomarkers in Primary and Metastatic Renal Cell Carcinoma Lesions: A Tissue Microarray Study
    Sung Han Kim, Weon Seo Park, Eun Young Park, Boram Park, Jungnam Joo, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung
    The Korean Journal of Urological Oncology.2016; 14(3): 152.     CrossRef
  • Long-term follow-up and clinical course of a rare case of von Hippel-Lindau disease: A case report and review of the literature
    YU ZOU, JINGJING XU, MINMING ZHANG
    Oncology Letters.2016; 11(5): 3273.     CrossRef
  • Genetic alterations in renal cell carcinoma with rhabdoid differentiation
    Carmen M. Perrino, Vishwanathan Hucthagowder, Michael Evenson, Shashikant Kulkarni, Peter A. Humphrey
    Human Pathology.2015; 46(1): 9.     CrossRef
  • High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma
    Cheol Lee, Jeong-Whan Park, Ja Hee Suh, Kyung Chul Moon
    Pathology - Research and Practice.2015; 211(11): 824.     CrossRef
  • A Case of Cutaneous Metastasis from a Clear Cell Renal Cell Carcinoma with an Eosinophilic Cell Component to the Submandibular Region
    Yusuke Amano, Sumie Ohni, Toshiyuki Ishige, Taku Homma, Tsutomu Yamada, Nobuyuki Nishimori, Norimichi Nemoto
    Journal of Nihon University Medical Association.2015; 74(2): 73.     CrossRef
Cyclooxygenase-2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma
Ji Won Lee, Jeong Hwan Park, Ja Hee Suh, Kyung Han Nam, Ji-Young Choe, Hae Yoen Jung, Ji Yoen Chae, Kyung Chul Moon
Korean J Pathol. 2012;46(3):237-245.   Published online June 22, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.3.237
  • 7,736 View
  • 48 Download
  • 16 Crossref
AbstractAbstract PDF
Background

The prognostic value of cyclooxygenase-2 (COX-2) in human renal cell carcinoma (RCC) remains unclear. The purposes of this study are to elucidate the clinical significance of COX-2 in clear cell RCC (CCRCC) and to assess the treatment effect of COX-2 inhibition on CCRCC cell lines.

Methods

Using tumor samples obtained from 137 patients who had undergone nephrectomy at Seoul National University Hospital, we evaluated COX-2 expression on immunohistochemistry. Moreover, we performed the cell proliferation assay using 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H tetrazolium bromide (MTT) and cell invasion assay. Thus, we evaluated the effect of meloxicam, an inhibitor of COX-2, in two human CCRCC cell lines.

Results

Cancer-specific survival (p=0.038) and progression-free survival (p=0.031) were shorter in the COX-2 high expression group. A multivariate logistic regression model showed that COX-2 expression was an independent risk factor for pTNM stage and Fuhrman nuclear grade. The MTT assay revealed that COX-2 inhibition led to the suppression of the proliferation of CCRCC cell lines. Moreover, it also reduced their invasion capacity.

Conclusions

This study postulates that COX-2 is a poor prognostic indicator in human CCRCC, suggesting that COX-2 inhibition can be a potential therapy in CCRCC.

Citations

Citations to this article as recorded by  
  • Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition
    Xiao-Jun Li, Ping Suo, Yan-Ni Wang, Liang Zou, Xiao-Li Nie, Ying-Yong Zhao, Hua Miao
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • The tumor microenvironment and immune targeting therapy in pediatric renal tumors
    Amy B. Hont, Benoit Dumont, Kathryn S. Sutton, John Anderson, Alex Kentsis, Jarno Drost, Andrew L. Hong, Arnauld Verschuur
    Pediatric Blood & Cancer.2023;[Epub]     CrossRef
  • Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT
    Priyanka F. Karmokar, Nader H. Moniri
    Cancer Cell International.2023;[Epub]     CrossRef
  • Flavonoids derived from Anemarrhenae Rhizoma ameliorate inflammation of benign prostatic hyperplasia via modulating COX/LOX pathways
    Xiaotong Cao, Ying Shang, Weigui Kong, Shuqing Jiang, Jun Liao, Ronghua Dai
    Journal of Ethnopharmacology.2022; 284: 114740.     CrossRef
  • Kirenol, darutoside and hesperidin contribute to the anti-inflammatory and analgesic activities of Siegesbeckia pubescens makino by inhibiting COX-2 expression and inflammatory cell infiltration
    Yu-Sang Li, Jian Zhang, Gui-Hua Tian, Hong-Cai Shang, He-Bin Tang
    Journal of Ethnopharmacology.2021; 268: 113547.     CrossRef
  • Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors
    Jefferson da Rocha Tenório, Leorik Pereira da Silva, Marília Gabriela de Aguiar Xavier, Thalita Santana, George João Ferreira do Nascimento, Ana Paula Veras Sobral
    European Archives of Oto-Rhino-Laryngology.2018; 275(9): 2341.     CrossRef
  • Retrospective evaluation ofCOX‐2 expression, histological and clinical factors as prognostic indicators in dogs with renal cell carcinomas undergoing nephrectomy
    S. Carvalho, A. L. Stoll, S. L. Priestnall, A. Suarez‐Bonnet, K. Rassnick, S. Lynch, I. Schoepper, G. Romanelli, P. Buracco, M. Atherton, E. M. de Merlo, A. Lara‐Garcia
    Veterinary and Comparative Oncology.2017; 15(4): 1280.     CrossRef
  • Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib
    Arancha Cebrián, Teresa Gómez del Pulgar, María José Méndez-Vidal, María Luisa Gonzálvez, Nuria Lainez, Daniel Castellano, Iciar García-Carbonero, Emilio Esteban, Maria Isabel Sáez, Rosa Villatoro, Cristina Suárez, Alfredo Carrato, Javier Munárriz-Ferránd
    Scientific Reports.2017;[Epub]     CrossRef
  • COX-2 expression in ovarian cancer: an updated meta-analysis
    Haiming Sun, Xuelong Zhang, Donglin Sun, Xueyuan Jia, Lidan Xu, Yuandong Qiao, Yan Jin
    Oncotarget.2017; 8(50): 88152.     CrossRef
  • COX-2 Expression in Renal Cell Carcinoma and Correlations with Tumor Grade, Stage and Patient Prognosis
    Hedieh Moradi Tabriz, Marzieh Mirzaalizadeh, Shahram Gooran, Farzaneh Niki, Maryam Jabri
    Asian Pacific Journal of Cancer Prevention.2016; 17(2): 535.     CrossRef
  • Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma
    Kosuke Saito, Eri Arai, Keiko Maekawa, Masaki Ishikawa, Hiroyuki Fujimoto, Ryo Taguchi, Kenji Matsumoto, Yae Kanai, Yoshiro Saito
    Scientific Reports.2016;[Epub]     CrossRef
  • Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma
    Łukasz Kuźbicki, Dariusz Lange, Agata Stanek-Widera, Barbara W. Chwirot
    Melanoma Research.2016; 26(5): 448.     CrossRef
  • New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis
    Honor J. Hugo, C. Saunders, R. G. Ramsay, E. W. Thompson
    Journal of Mammary Gland Biology and Neoplasia.2015; 20(3-4): 109.     CrossRef
  • The Role of Prostaglandin E2 in Renal Cell Cancer Development: Future Implications for Prognosis and Therapy
    Katarzyna Kaminska, Cezary Szczylik, Fei Lian, Anna M Czarnecka
    Future Oncology.2014; 10(14): 2177.     CrossRef
  • Genomics and epigenomics of clear cell renal cell carcinoma: Recent developments and potential applications
    Małgorzata Rydzanicz, Tomasz Wrzesiński, Hans A.R. Bluyssen, Joanna Wesoły
    Cancer Letters.2013; 341(2): 111.     CrossRef
  • Quantitative Assessment of the Association of COX-2 (Cyclooxygenase-2) Immunoexpression with Prognosis in Human Osteosarcoma: A Meta-Analysis
    Zhe Wang, Maolin He, Zengming Xiao, Hao Wu, Yang Wu, Dominique Heymann
    PLoS ONE.2013; 8(12): e82907.     CrossRef
Markers for Screening Lynch Syndrome Are Reliable and Useful for Identifying the Specimen Mislabeling
Sun-ju Byeon, Jiwoon Choi, Kyung Han Nam, Bo-Gun Jang, Hee Eun Lee, Min A Kim, Woo Ho Kim
Korean J Pathol. 2012;46(2):131-136.   Published online April 25, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.2.131
  • 7,072 View
  • 67 Download
  • 2 Crossref
AbstractAbstract PDF
Background

During specimen processing in surgical pathology laboratories, specimen-related adverse events (SRAEs), such as mislabeling and specimen mixed-up might occur. In these situations, molecular techniques using short tandem repeat (STR) loci are required to identify the personal identity. Microsatellite instability (MSI) test is widely used for screening the hereditary non-polyposis colon cancer (Lynch syndrome) in surgical pathologies using polymorphic STR markers. We tried to evaluate the applicability of the MSI test for SRAEs.

Methods

We obtained 253 MSI test results to analyze the allele frequencies. After calibrating the estimated nucleotide lengths, we calculated the allele frequencies, a random match probability, and a likelihood ratio (LR) of three dinucleotide STR markers (D5S349, D17S250, and D2S123).

Results

The distribution of LR was 136.38 to 5,606,213.10. There was no case of LR<100. In addition, there were 153 cases (60.5%) of LR ranging from 100 to 10,000 and 100 cases (39.5%) of LR>10,000. Furthermore, the combined probability of identity was 9.23×10-4 and the combined power of exclusion was 0.99908.

Conclusions

Using the three STR markers that are recommended for MSI test, all the cases were positively identified in 1% range and about one-third cases showed high LR (>10,000). These results showed that MSI tests are useful to screen the personal identity in case of SRAE in pathology laboratories.

Citations

Citations to this article as recorded by  
  • Lost, mislabeled, and mishandled surgical and clinical pathology specimens: A systematic review of published literature
    Heather J Carmack, Braidyn S Lazenby, Kylie J Wilson, Jamie N Bakkum-Gamez, Leslie Carranza
    American Journal of Clinical Pathology.2024; 162(4): 349.     CrossRef
  • Sensitivity and polymorphism of Bethesda panel markers in Chinese population
    Yanying Zheng, Jie Chen, Xiang Zhang, Ling Xie, Yifen Zhang, Yi Sun
    Bulletin du Cancer.2020; 107(11): 1091.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP